Pei‐Min Hsieh
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Liver physiology and pathology 2
- Liver Disease and Transplantation 2
-
- Pancreatic and Hepatic Oncology Research 3
- Peptidase Inhibition and Analysis 2
-
- Liver Disease Diagnosis and Treatment 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Yaw‐Sen ChenChih‐Wen LinChia‐Chang HsuChung-Hsu LaiHung‐Yu LinChao‐Tien HsuGin‐Ho LoGuiting Lin
- Cited by
- HepatologyOncologyEpidemiology
- Partner nations
- TaiwanUnited StatesMexico
In The Last Decade
Pei‐Min Hsieh
18 papers receiving 340 citations
Peers
Comparison fields: 5 of 53
- Hepatology 103
- Oncology 112
- Epidemiology 137
- Neurology 60
- Cancer Research 49
Countries citing papers authored by Pei‐Min Hsieh
This map shows the geographic impact of Pei‐Min Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Min Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Min Hsieh more than expected).
Fields of papers citing papers by Pei‐Min Hsieh
This network shows the impact of papers produced by Pei‐Min Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Min Hsieh. The network helps show where Pei‐Min Hsieh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pei‐Min Hsieh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 19 | |
| 8 | 2020 | 27 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 22 | |
| 11 | 2018 | 18 | |
| 12 | 2017 | 14 | |
| 13 | 2012 | 4 | |
| 14 | 2012 | 10 | |
| 15 | 2011 | 1 | |
| 16 | 2009 | 44 | |
| 17 | 2009 | 68 | |
| 18 | 2009 | 20 | |
| 19 | 2003 | 54 |
About Pei‐Min Hsieh
Pei‐Min Hsieh is a scholar working on Hepatology, Pathology and Forensic Medicine and Cancer Research, having authored 19 papers that have together received 352 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), Liver physiology and pathology (2 papers), Liver Disease and Transplantation (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hepatology (103 citations), Oncology (112 citations) and Epidemiology (137 citations). Pei‐Min Hsieh has collaborated with scholars based in Taiwan, United States and Mexico. Frequent co-authors include Yaw‐Sen Chen, Chih‐Wen Lin, Chia‐Chang Hsu, Chung-Hsu Lai, Hung‐Yu Lin, Chao‐Tien Hsu, Gin‐Ho Lo, Guiting Lin, Tom F. Lue and Ching‐Shwun Lin. Their work appears in journals such as PLoS ONE, Medicine and World Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.